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Polyprotein allergens are a family of structurally homologous molecules from parasitic nematodes which
induce specific immunoglobulin E in infected individuals. We show here that both H-2 and non-H-2 factors
determine the ability of mice to generate T- and B-cell responses to the filarial polyprotein allergen (Brugia
malayi gp15/400). Further, H-2 and non-H-2 genes can complement one another to overcome nonresponsive-
ness to this molecule. However, these genetic restrictions govern only responses to the native glycoprotein and
all strains of mice respond equivalently when immunized with a recombinant polypeptide. Overlapping
fragments of gp15/400 were constructed to compare the T-cell and antibody responses to native versus
recombinant gp15/400 in responder (BALB/c H-2d) and nonresponder (B10.D2 H-2d, CBA H-2k, and BALB.K
H-2k) strains. BALB/c mice generated T-cell responses to the same fragment (positions 89 to 133 and 1 to 21)
whether immunized with native or recombinant material, although the antibody responses differed in fine
specificity. H-2kmice, unresponsive to the native molecule, generated T cells responsive to the centrally located
peptide (positions 57 to 100) only when immunized with the recombinant. Antibody responses in H-2k mice
were directed at the peptide (positions 11 to 67) which is glycosylated in the native molecule. Our findings
suggest that recognition of gp15/400 is affected by modifications that occur in the parasite but are absent when
the molecule is produced in bacteria. This study provides a detailed evaluation of the immune response to an
important nematode antigen as a start to the unraveling of the complex interaction of these multicellular
parasites with mammalian hosts.
Over 75 million people in the tropics are infected with the
causative agents of lymphatic filariasis: Brugia malayi, Brugia
timori, and Wuchereria bancrofti (34). These parasitic nema-
todes are transmitted by mosquitoes and reside in the lymphat-
ics, where adult females produce large numbers of microfi-
lariae that circulate in the bloodstream. Infection with filarial
parasites leads to a spectrum of host immune responses, rang-
ing from a remarkable absence of responsiveness to severe
immunopathological conditions, such as elephantiasis (19, 23).
The way in which the immune system recognizes and responds
to these complex multicellular organisms determines whether
infection leads to protective immunity, tolerance, or disease
development (13, 19, 23). Information regarding immune rec-
ognition in most nematode infections, including lymphatic fi-
lariasis, has been largely restricted to crude extracts of whole
parasites. However, the ability to recognize individual parasite
molecules is under host genetic control and it is these antigen-
specific responses that may determine whether the host re-
sponse is appropriate or detrimental. Thus, to begin to under-
stand immune recognition of parasitic nematodes it is imperative
to look at individual antigens and to combine studies of anti-
body reactivity with an analysis of the T-cell responses that are
elicited.
gp15/400 is a surface-associated molecule found in each of
the Brugia life cycle stages and is broadly distributed in all
tissues of the worm (29). It is released into culture medium in
vitro and is a key component of the excretory-secretory mate-
rial produced by the parasite (29). Although highly immuno-
genic in many infected individuals, gp15/400 does not elicit an
antibody response in some people with otherwise elevated
immune responses to Brugia organisms. Interestingly, there is a
considerably lower frequency of the DR2 major histocompat-
ibility complex (MHC) class II allele in gp15/400 nonre-
sponders than in the rest of the population (35). Differential
antibody isotype responses to gp15/400 have also been re-
ported among individuals in separate clinical categories. Ele-
phantiasis patients have consistently strong immunoglobulin E
(IgE) responses to this molecule, in contrast to patently in-
fected but asymptomatic persons (24). Asymptomatic individ-
uals tend to have low IgE levels together with high IgG4 levels,
which may function to block the damaging effects of IgE (10).
Consistent with the heterogeneity of the immune response in
humans, a striking restriction of the antibody response to gp15/
400 has been observed in mice (15).
gp15/400 is a member of a phylogenetically conserved family
of molecules termed the nematode polyprotein allergens
(NPA) (6, 21, 25). These molecules frequently elicit IgE re-
sponses in infected hosts, as seen in Brugia infection. NPA are
composed of a series of direct repeats with regularly spaced
proteolytic cleavage sites such that the molecules are processed
into multiple polypeptides of approximately 15 kDa from a
large 400-kDa precursor (21, 32). In Brugia sp., this cleavage is
incomplete and a ‘‘ladder’’ of polypeptides in molecular mass
multiples of 15 kDa is observed when the polypeptides are
separated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE). Each repeat of Brugia gp15/400 con-
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tains a single site for N-linked carbohydrate attachment which
is glycosylated in the native molecule (32).
The NPA family was defined by the prototype molecule in
Ascaris sp., ABA-1, which is the major constituent of the body
fluid and is responsible for observed allergic responses to this
organism (4, 20, 30). Interestingly, the antibody response to
ABA-1 is also under strict genetic (H-2) control in mice and
there is distinct polymorphism among human ascariasis cases,
with most individuals producing no antibody to ABA-1 (12).
The capacity of NPA to elicit potentially damaging IgE re-
sponses may lead to modulation of the immune response to
this molecule during both Brugia and Ascaris infections. These
mechanisms of control may differ in Brugia and Ascaris spp. but
lead to the same consequence: that many individuals are pre-
vented from responding in the context of natural infection.
In the absence of a good animal model for lymphatic filar-
iasis, we have chosen to study the response to gp15/400 by
implantation of live worms into the peritoneal cavities of mice,
as well as by adjuvant-assisted immunization. In all of the
mouse strains used in this study, adult worms survive for more
than 8 weeks in the peritoneal cavity, with the female parasites
continuously producing viable microfilariae. Although it is not
the natural context of infection, the ability to use defined
murine reagents and inbred strains for analysis of genetic re-
sponsiveness provides the most suitable starting point to un-
ravel immune responses to individual parasite antigens. In this
study, we analyzed T- and B-cell responses to both the native
molecule and an Escherichia coli recombinant in detail not
previously attempted for antigens from nematode parasites.
We found that several inbred mouse strains completely fail to
recognize the native molecule and that this failure is controlled
by both H-2 and non-H-2 genes. Interestingly, we found that
these restrictions are invoked only when an animal is exposed
to the native molecule whereas genetic control of the anti-
gp15/400 response is lost when the recombinant form is pre-
sented. By using the recombinant protein, we mapped B- and
T-cell determinants on this antigen to examine why sites on the
native molecule may not be accessible to the immune system.
MATERIALS AND METHODS
Parasite material. Live adult worms were obtained from B. malayi-infected
jirds (Meriones unguiculatus) purchased from TRS Laboratories, Athens, Ga.
Adult worms were harvested from the peritoneal cavities of the jirds. B. malayi
antigen (Bma) was prepared by homogenization of adult worms in phosphate-
buffered saline (PBS) on ice followed by centrifugation at 10,000 3 g for 20 min.
The supernatant was passed through a 0.2-mm-pore-size filter, and the protein
concentration was determined by Bradford analysis. A parasite extract enriched
for gp15/400 was made by incubation of 50 adult worms in 200 ml of 5%
2-mercaptoethanol in PBS at 378C for 30 min followed by a single wash with 150
ml of PBS (18). The 2-mercaptoethanol strip and wash were pooled and used for
immunizations.
Amplification and cloning of gp15/400 fragments. Overlapping fragments of
the gp15/400 gene were obtained by PCR amplification. The absence of introns
in this gene (32) permitted use of genomic Brugia DNA prepared from micro-
filariae as the template DNA. Oligonucleotides were synthesized with 59 EcoRI
sites and 39 XbaI sites for directional, in-frame cloning into the pMAL-c vector
from New England Biolabs (Beverly, Mass.). Downstream primers included an
in-frame stop codon. PCR amplification and cloning into the expression vector
were performed by using standard techniques (27). Fusion proteins represent
three overlapping fragments encompassing slightly more than a single repeat unit
of gp15/400. The fragments overlap by at least 10 amino acids, and Ld143
contains all three subfragments. Recombinant P15 (rP15) has been described
previously (24) and contains one full repeat unit and a polyhistidine tail. A map
of these constructs is shown in Fig. 1.
Selection of pMAL-c recombinants and verification of expression were done as
described by the manufacturer (New England Biolabs). We produced Ld57 with
primers LAD1 and LAD2, Ld44 with LAD3 and LAD4, Ld65 with LAD5 and
LAD6, and Ld143 with LAD1 and LAD6. Oligonucleotide sequences used for
amplification were as follows: LAD1, 59-GAC-GAA-TTC-CGG-ACG-CAT-
CTA-AGT-39; LAD2, 59-CCT-TCT-AGA-TTA-ACG-ACA-ACC-TCC-ACG-
39; LAD3, 59-GGA-GAA-TTC-GAA-GCC-GGT-GAG-AAA-CT-39; LAD4, 59-
TGT-TCT-AGA-ATT-TAA-TCT-ACT-TTA-GCT-39; LAD5, 59-AAA-GAA-
TTC-GGA-CTC-GGT-CAG-G-39; and LAD6, 59-TTC-TCT-AGA-TTA-GGC-
ATC-CGT-AAG-CCA-39. The correct amino acid sequence of each clone was
verified by sequencing of plasmid DNA with the malE sequencing primer pur-
chased from New England Biolabs.
P-RUNG was constructed by PCR amplification and cloning into pET-15b
(Novagen, Madison, Wis.) with an intermediate step of cloning into pBluescript
(Stratagene, La Jolla, Calif.). The upstream oligonucleotide was designed with an
NcoI site which generated a methionine immediately prior to Asp-1 of the
gp15/400 repeat. The cloned product represents one repeat of the ladder begin-
ning with Asp-1, the first amino acid following the proteolytic cleavage site, and
ending with Arg-132 (32). Oligonucleotides used for amplification were 59-GGA-
TCG-ACA-TAC-CAT-GGA-TAA-CCA-TGA-GCA-TA-39 and 59-GCT-CCC-
TAG-GTT-ATC-GTT-TAT-GTC-GAT-CCT-CAT-AGA-39. The PCR product
was amplified from genomic Brugia DNA and cloned into SmaI-digested pBlue-
script by blunt-end ligation. The P-RUNG sequence was then subcloned into
pET-15b with NcoI and XhoI. All cloning steps used the TG2 host cells in which
the recombinant was maintained. For expression, the plasmid was transferred
into host strain BL21(DE3) as described below. The recombinant pET-15b,
designated pET.Bm.RUNG, was confirmed by sequence analysis.
Growth and purification of gp15/400 recombinant molecules. Cloning and
purification of rP15 have been described previously (24). The expressed protein
contains one full repeat unit with a polyhistidine tail and was purified by nickel
affinity chromatography (24). Maltose-binding protein (MBP) fusion proteins
Ld57, Ld44, Ld65, and Ld143 were purified as described by the New England
Biolabs protocols, except that no azide was used in any of the buffers to preclude
FIG. 1. Map of recombinant proteins used to evaluate T- and B-cell responses to gp15/400. The number of repeats in the precursor molecule has been estimated
to be around 20. The Ld set of recombinant proteins are fusions with MBP. rP15 has a polyhistidine tail (24). All MBP fusion proteins were made by PCR amplification
of genomic DNA and directional cloning into the pMAL-c vector. The dark triangles indicate glycosylation sites.
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interference with T-cell assays. Briefly, E. coli lysates were passed over an amy-
lose resin column which was washed extensively and the purified fusion proteins
were eluted with 10 mM maltose. P-RUNG was produced by transformation of
pET.Bm.Rung into expression host BLD21(DE3). A single transformant was
used to inoculate 100 ml of Luria broth with ampicillin. Expression was induced
with isopropyl-b-D-thiogalactopyranoside (IPTG), and the host cells were lysed
by lysozyme treatment and sonication as described by the manufacturer (Nova-
gen). The supernatant was then dialyzed against 20 mM Tris (pH 8) prior to
purification by fast protein liquid chromatography (FPLC) with an anion-ex-
change column (Mono Q HR 5/5; Pharmacia, Uppsala, Sweden). P-RUNG
eluted at 50 mM NaCl. All purified recombinant proteins were dialyzed against
PBS for use in immunological assays. Protein purity was assessed by SDS-PAGE.
Immunization of mice. Male BALB/c, CBA/Ca, B10.D2, and BALB.K mice
were obtained from Harlan-UK (Bicester, Oxfordshire, England) at 6 to 8 weeks
of age. BALB.K males were bred with B10.D2 females. The F1 offspring were
used at 8 weeks of age.
(i) Adjuvant-assisted immunization. The mice were immunized by subcuta-
neous injection with 10 mg of Bma emulsified in complete Freund’s adjuvant
(CFA). Four to five weeks later, they were boosted in the footpad with a
2-mercaptoethanol strip of adult worms (see above) emulsified in incomplete
Freund’s adjuvant. Sera were taken, and the draining popliteal lymph nodes were
removed 10 days after the boost.
(ii) Infection with live worms. The peritoneal cavities of mice were implanted
with six viable adult B. malayi females and three to six adult males. Sera were
taken and spleens were removed 3 to 4 weeks following implantation.
(iv) Immunization with rP15. Mice were given a single subcutaneous immu-
nization with 10 mg of rP15 emulsified in CFA, and sera were taken 3 to 7 weeks
later.
Preparation of T-cell lines. BALB/c and CBA mice were immunized subcu-
taneously with a preparation of rP15 purified by separation on SDS–12% PAGE
and transfer to nitrocellulose. The nitrocellulose paper was dissolved in dimethyl
sulfoxide and mixed with CFA for the primary immunization. Six weeks later,
mice were boosted with 10 mg of rP15 (affinity but not gel purified) in incomplete
Freund’s adjuvant. Popliteal lymph nodes were taken 10 days following the boost
and stimulated in vitro with 20 mg of rP15 per ml. Five days following primary
stimulation, the cells were washed and ‘‘rested’’ for 7 days by addition of mito-
mycin C-treated splenocytes (feeder cells) and 10% mouse-derived concanavalin
A-stimulated medium. This was followed by additional stimulation with antigen
and feeder cells for 6 days and another 4-day rest with mouse-derived concanava-
lin A-stimulated medium and feeder cells. The third in vitro stimulation was
done with FPLC-purified P-RUNG for 5 days followed by a 1-week rest prior to
assay.
T-cell assays. (i) Primary assays. Popliteal lymph node cells were cultured in
complete medium at 5 3 105 cells per well in U-bottom microtiter plates with 10
mg of antigen per ml. At 65 h, supernatants were removed for cytokine analysis.
Production of cytokines was assessed by measuring the proliferation of the NK
cell line (31), which is responsive to both interleukin 2 (IL-2) and IL-4.
(ii) Assay of T-cell lines. T cells were cultured in complete medium at 1 3 105
cells per well in U-bottom microtiter plates with 10 mg of antigen per ml and 5
3 105 mitomycin C-treated splenocytes per well as antigen-presenting cells.
Cytokine analysis was performed with the NK cell line by addition of neutralizing
antibody to IL-2 (S4B6) or IL-4 (11B11) and comparison to a standard curve
determined with recombinant IL-2 and IL-4 as described previously (16).
Enzyme-linked immunosorbent assay (ELISA). Nunc Maxisorp Immuno
plates were coated by incubation overnight at 48C with 10 mg of Bma per ml or
5 mg of purified fusion protein per ml in 0.1 M carbonate buffer (pH 9.2). Plates
were blocked with 5% bovine serum albumin for 30 min at 378C. Mouse sera
were diluted 1/100 in PBS–0.05% Tween 20 and incubated for 3 h at 378C. Plates
were washed with PBS–0.05% Tween 20 and then incubated with peroxidase-
conjugated goat anti-mouse IgG (gamma chain specific; BioRad, Richmond,
Calif.) diluted 1/2,000 in PBS–0.05% Tween 20. Reactions were detected with
ABTS substrate (KPL Biotechnology, Gaithersburg, Md.). The isotype ELISA
was performed as described previously (16).
RESULTS
The antibody response to native gp15/400 is controlled by
factors both within and outside the H-2 complex. Previous
experiments with mice implanted with live adult worms and
using immunoprecipitation of native antigen (15) have shown
that BALB/c mice make antibody to gp15/400 whereas B10.D2
mice do not. This demonstrated that the antibody response to
this molecule is governed by a non-H-2-encoded factor(s), as
both strains of mice share the H-2d gene complex. In addition,
B10.BR and CBA mice (H-2k) do not make antibody (15). We
first extended these studies by implanting BALB.K (H-2k)
mice, in addition to BALB/c, CBA, and B10.D2 mice, with
adult worms for 4 weeks. Sera were tested against recombinant
Ld143 (Fig. 1) by ELISA with a gamma chain-specific second
antibody to detect all T-helper cell-dependent antibody iso-
types. As demonstrated in Fig. 2A, only BALB/c mice were
able to make antibody to gp15/400 following implantation with
live adult worms. All animals gave equivalently high (optical
density, .0.8) responses to Bma, demonstrating that the ab-
sence of response in CBA, BALB.K, and B10.D2 mice was not
due to a general immunosuppressive component produced by
the parasite. The inability of BALB.K mice to make antibody
to gp15/400 showed that the response requires both an appro-
priate H-2 allele (H-2d) and a background gene represented in
the BALB congenic strains.
We also evaluated the abilities of these strains of mice to
make antibody to gp15/400 when immunized with Brugia ex-
tract emulsified in CFA and boosted with a preparation en-
riched for gp15/400. The results are shown in Fig. 2B. The
response was similar to that of mice experiencing live infection
except that adjuvant-assisted immunization and boosting gen-
erated a response in some B10.D2 mice. This suggests that the
factors outside the H-2 that determine antibody responses are
less stringent than those imposed by the MHC itself.
Analysis of the sera by immunoprecipitation of 125I-labeled
adult parasite extract gave an identical pattern of results (data
not shown). Therefore, absence of a response by recombinant-
FIG. 2. Antibody responses to native gp15/400 in four strains of mice. The
antibody responses to Ld143 for individual mice are shown for mice whose
peritoneal cavities were implanted with live adult parasites for 4 weeks (A) or
mice immunized with Bma in CFA and boosted with a preparation enriched for
gp15/400 (B). The sera were tested by ELISA with a horseradish peroxidase-
conjugated anti-murine gamma chain second antibody. The results are shown as
optical densities (OD) with the response to MBP subtracted from the response
to Ld143.
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based ELISA was not due to specificity of the antisera for
native determinants or insensitivity of the assay system.
All mouse strains can make antibody following immuniza-
tion with rP15. A striking contrast to the response seen fol-
lowing exposure to native antigen was found when mice were
given a single subcutaneous immunization with purified rP15.
All strains of mice were able to make a significant IgG re-
sponse to Ld143 3 to 7 weeks following the immunization (Fig.
3). This demonstrated that the inability of CBA and BALB.K
mice to mount an antibody response to the native molecule was
not due to an absence of T-cell determinants recognizable by
H-2k strains and suggested that a structural or contextual fea-
ture of native gp15/400 blocks H-2k responsiveness. In addi-
tion, the non-H-2-controlled mechanism that prevents B10.D2
mice from responding to gp15/400 in the context of infection is
overcome by immunization with the recombinant molecule. An
isotype analysis of the response to rP15 is shown for CBA mice
in Fig. 4. IgG1, IgG2a, and IgG2b were the most abundant
antigen-specific isotypes generated, verifying that the produc-
tion of antibody to the recombinant required T-cell help.
The recombinant molecule elicits antibody to the amino-
terminal fragment, while native gp15/400 generates antibody
to conformational determinants. E. coli-derived fusion pro-
teins representing three overlapping fragments of the gp15/400
repeat unit (Fig. 1) were used to analyze the fine specificity of
the immune response to native and recombinant antigens.
When the subfragments were used to map the antibody re-
sponse to rP15, all four strains made antibody to Ld57, the
amino-terminal fragment which is glycosylated in the native
molecule (Fig. 3). This was particularly striking in H-2k mice
(BALB.K and CBA), which responded poorly to the other
FIG. 3. Antibody responses to subfragments in four strains of mice immu-
nized with rP15. The antibody responses to individual fusion proteins in mice
immunized with rP15 were tested by ELISA. The response to MBP was sub-
tracted. Standard deviations between individual mice are shown and represent
the responses of two to four mice per group. No specific antibody was detected
in sera from control mice immunized with CFA alone. O.D., optical density.
FIG. 4. Analysis of the rP15-specific antibody isotype response in CBA mice.
Sera from mice immunized with rP15 were tested against Ld143 by ELISA.
Peroxidase-conjugated antibodies against murine immunoglobulin subclasses
were used to evaluate the sera. The results are shown as optical densities (OD)
with the response to MBP subtracted from the response to Ld143. The standard
deviation represents the responses of three mice per group.
FIG. 5. Antibody responses to subfragments in BALB/c mice exposed to
native antigen. The antibody responses to individual fusion proteins in animals
either implanted with live worms or immunized with Bma and boosted with a
gp15/400-enriched fraction were tested by ELISA. The response to MBP was
subtracted. Standard deviations between individual mice are shown and repre-
sent the responses of six mice. No specific antibody was detected in sera from
control mice. O.D., optical density.
FIG. 6. T-cell responses to native gp15/400 in four strains of mice. T-cell
responses to individual fusion proteins and Bma were measured after mice were
immunized with Bma and boosted with a gp15/400-enriched preparation. Re-
sponses (shown in cpm) were measured by proliferation of the IL-2–IL-4-sensi-
tive NK cell line (31) in response to T-cell assay supernatants. Standard devia-
tions between individual mice are shown and represent the responses of three
BALB/c, three CBA, five B10.D2, and five BALB.K mice.
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fragments. H-2d mice (BALB/c and B10.D2) responded to
both Ld57 and Ld65, the fragment which contains the T-cell
determinant recognized by these strains (see below).
A different pattern was observed when the subfragments
were used to map the antibody response to native gp15/400
from responder BALB/c mice which had been either implanted
with adult worms or immunized with Bma and boosted with a
gp15/400-enriched fraction (Fig. 5). The antibody response was
found to be directed almost entirely to Ld143 (and rP15; data
not shown) and not to the individual subfragment peptides.
The structures of NPA, including gp15/400, are predicted to
form a four-helix bundle and are known to be extremely stable
and resistant to denaturation (21). Full-length recombinant
proteins Ld143 and rP15 are apparently able to take on this
structure (11), whereas the individual fragments almost cer-
tainly do not. Thus, the ability to respond only to full-length
constructs suggests that animals exposed to native gp15/400
make an antibody response that recognizes conformational
rather than linear epitopes.
T-cell responses following exposure to native gp15/400 are
genetically restricted. The inability of BALB.K, CBA, and
most B10.D2 mice to make antibody was reflected in the ab-
sence of gp15/400-specific T-cell cytokine responses when mice
were immunized with Bma and boosted with a preparation
enriched for gp15/400 (Fig. 6). The cells from the draining
lymph node were evaluated for specific T-cell responses to
gp15/400-derived fusion proteins. T-cell responsiveness was
assessed by measurement of T-cell-derived cytokines in re-
sponse to specific antigen by using a cell line highly sensitive to
both IL-2 and IL-4 (31). Despite strong, specific responses to
Bma in all four strains of mice, only BALB/c mice showed
significant reactivity to any of the gp15/400-derived fusion pro-
teins. BALB/c mice gave a strong response to Ld143. In addi-
tion, this result defined the carboxyl-terminal fragment, Ld65,
as the target of the T-cell response in BALB/c mice. gp15/400-
specific cytokine production by BALB/c mice was predomi-
nantly IL-4 (data not shown).
T-cell lines to rP15 define H-2d and H-2k T-cell sites on
gp15/400. Analysis of the T-cell response to the recombinant
molecule demonstrated that BALB/c (H-2d) and CBA (H-2k)
mice recognize distinct domains and epitopes. T-cell lines were
derived by rP15 immunization of mice and culture of the lym-
phocytes with rP15 for two rounds of stimulation and rest.
These T-cell lines were then stimulated with another gp15/400
recombinant, P-RUNG, which represents a single repeat of the
ladder with no polyhistidine tail. Selection on this FPLC-puri-
fied molecule reduced background responses to E. coli con-
taminants. Specific cytokine production by these recombinant-
specific T-cell lines shows that BALB/c mice recognize Ld65,
the same determinant recognized by gp15/400-specific T cells,
whereas CBA mice recognize the central fragment, Ld44 (Fig.
7). Generation of the optimal stimulatory peptides may require
full-length Ld143, as the response to the entire repeat was
greater than those to the individual subfragments. The cyto-
kine responses of these T-cell lines determined by NK cell
analysis were exclusively IL-4 with no antigen-specific IL-2
production. The strictly Th2 cytokine profile of these T-cell
lines was probably due to the IL-4-rich conditioned medium in
which they were maintained but may have been influenced by
the nature of the antigen.
Complementation of H-2 and non-H-2 genes in the antibody
response to gp15/400. Nonresponder BALB.K and B10.D2
mice were genetically crossed, and the F1 generation was im-
planted with live parasites. The antisera from these mice were
tested by ELISA and showed excellent antibody responses to
gp15/400 (Fig. 8). Thus, as would be expected from the respon-
siveness of BALB/c mice, the BALB background was able to
present antigen effectively in the context of H-2d, showing that
non-H2 genes controlling the inability of B10.D2 mice to re-
spond are recessive.
FIG. 7. T-cell responses to subfragments in CBA and BALB/c mice immu-
nized with rP15. T-cell responses to individual fusion proteins were evaluated
with rP15-specific T-cell lines. Results are shown as units of IL-4 produced per
milliliter as determined with the indicator NK cell line sensitive to IL-2 and IL-4.
No antigen-specific IL-2 was produced. The standard deviation between tripli-
cate wells was ,10%.
FIG. 8. Antibody responses in B10.D2, BALB.K, and B10.D2 3 BALB.K F1
mice following implantation with adult parasites. Antibody responses of im-
planted mice to MBP, Ld143 (solid bars), and Bma (hatched bars) were tested by
ELISA. The response to MBP was subtracted. Standard deviations between
individual mice (four per group) are shown. No specific responses were detected
in control unimmunized mice. The numbers are optical densities.
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Nematode parasites frequently establish long-lived chronic
infections in their vertebrate hosts that are characterized by
the ability of the parasites to both modulate and evade the host
immune response. Numerous strategies of immune evasion,
from masking, shedding, and changing of target antigens to
production of anti-inflammatory factors, have been identified
(2, 17). Additional mechanisms, such as interference with an-
tigen processing have been proposed as means of immune
modulation, but evidence remains sparse (3, 33). In infections
such as filariasis, a spectrum of clinical manifestations is seen,
as well as a wide variation in the duration of parasite survival.
This suggests that host genetics can greatly influence the effi-
cacy of these evolutionary strategies to alter or avoid immune
recognition. Studies with inbred mice have verified that the
host genetic background can profoundly alter the outcome of
infection with parasitic nematodes (2, 8, 9, 22).
The gp15/400 molecule from B. malayi evokes a heteroge-
neous response in the human population (24) that is reflected
in a striking restriction of the antibody response in mice (15).
Thus, it provides a model system with which to assess in detail
the influence of host genetics on the B-cell and T-cell re-
sponses to an important nematode antigen. In this study, four
inbred strains of mice were exposed to gp15/400 in three con-
texts: by infection with live parasites, by adjuvant-assisted im-
munization with the native molecule, and by immunization
with a recombinant molecule. It is not practical to purify suf-
ficient quantities of native gp15/400 from the parasite, and
therefore, reactivity to the native molecule was studied by
immunization with whole-parasite extracts or by infection. Our
results demonstrated that the antibody and T-cell responses to
the native molecule are controlled by factors both within and
outside the H-2 complex but that these restrictions are over-
come by immunization with an E. coli-derived recombinant.
This suggests that recognition of gp15/400 by T cells, and
therefore B cells, is affected by secondary or posttranslational
modifications that occur in the parasite but are absent when
the molecule is produced in bacteria. These may include N-
linked glycosylation, dimer formation, cofactor binding, or the
mode of protein folding.
Recognition of Brugia gp15/400 may be critically influenced
by the presence of an N-linked carbohydrate on the amino-
terminal portion of the repeat unit. Strains of mice which are
nonresponsive to native gp15/400 (CBA and BALB.K) make
antibody to the amino-terminal fragment (Ld57) when primed
with the recombinant molecule and generate a T-cell response
to a fragment adjacent to the glycosylation site (Ld44). It is
possible that the presence of the carbohydrate blocks the abil-
ity of this molecule to be processed or appropriately recog-
nized by T cells and thus prevents effective antibody produc-
tion. Our data show that BALB/c mice which respond to a
more distant site (Ld65) are capable of generating effective T-
and B-cell responses irrespective of glycosylation in the amino-
terminal domain. Glycosylation of antigenic peptides may af-
fect T-cell responses at the level of antigen uptake, peptide
processing, MHC binding, or TCR recognition. N-Glycanase
treatment of Bma, although effectively deglycosylating gp15/
400, did not stimulate a B- or T-cell response in BALB.K mice
(data not shown). However, N-glycanase, in addition to remov-
ing the N-linked carbohydrate, converts the asparagine on the
amino acid backbone to an aspartic acid. This change may alter
the site for cleavage by lysosomal enzymes and prevent the
generation of appropriately processed peptides.
Other aspects of the higher-ordered structure of this mole-
cule could influence T-cell recognition. For example, human
chorionic gonadotrophin, a dimer of noncovalently associated
subunits, cannot be processed and appropriately presented by
antigen-presenting cells in native form, yet the free subunits
are effectively recognized (26), demonstrating that the quater-
nary structure of an antigen can be important in antigen pro-
cessing. Although recombinant gp15/400 is known to form a
homodimer of the 15-kDa subunit (11), as is the native ABA-1
molecule of Ascaris suum (4), it is not certain whether this is
structurally identical to native gp15/400. In addition, gp15/400
is known to be a fatty acid- and retinoid-binding protein (11)
and the natures of the molecules bound to the native and
recombinant forms of gp15/400 may differ. Thus, dimer forma-
tion or cofactor binding by native gp15/400 may alter its fate in
the antigen-processing pathway and prevent access to the rel-
evant T-cell sites.
Antibody mapping of the BALB/c response to the native
molecule demonstrated poor reactivity to linear determinants,
indicating that the antibody response is predominantly to con-
formational determinants. Receptor-mediated uptake by anti-
gen-specific B cells can influence which peptides are made
available for MHC binding by protecting certain fragments
from proteolytic degradation (7). Thus, the inability to respond
to native gp15/400, although apparent at both the B- and T-cell
levels, may be caused by inability of B cells to recognize or
process the appropriate determinants because of constraints
on antibody recognition by tertiary-quaternary structure. More
specifically, in H-2k mice, recognition of the amino-terminal
portion (Ld57) by specific immunoglobulin receptors on anti-
gen-presenting B cells may be required for appropriate pro-
cessing and presentation of the immunogenic peptide in the
central fragment.
The polyprotein nature of gp15/400 may also play a role in
T-cell recognition. However, high levels of IgM to gp15/400 are
not observed (data not shown), and thus, the classic model of
a repetitive antigen diverting the immune response by inducing
a T-independent reaction (28) seems unlikely. In addition, the
molecules that elicit T-independent responses, such as the
circumsporozoite protein of malaria, contain much smaller
repeats able to cross-link B-cell receptors and induce produc-
tion of T-independent antibodies (28). Further, although the
precursor exists as a polyprotein, B. malayi secretes large
amounts of gp15/400 that have been cleaved to single or double
repeats. The polyprotein nature of gp15/400 and the other
NPA may be related more to the function of the molecule than
to a mechanism of immune evasion.
The finding that non-MHC genetic factors control the ability
to make antibody is unusual. Most restricted antibody re-
sponses to individual proteins have been linked directly to the
H-2 complex. The inability of B10.D2 mice to respond follow-
ing implantation with live worms demonstrates that the pro-
cessing or recognition of gp15/400 is influenced by non-H-2
genes. This response can be partially overcome when an adju-
vant is used, in a manner analogous to the response seen with
A. suum, in which immunization of mice with native ABA-1 in
CFA circumvents the MHC restriction (5). Further, when T-
cell lines to whole Brugia extract were derived from B10.D2
mice implanted with live parasites, a small response to Ld65
and Ld143 was generated (1). This demonstrated that these
animals have the capacity to generate a T-cell response to
gp15/400, but at a very low level.
The mechanism of the non-H-2-controlled response to gp15/
400 is more difficult to interpret than the H-2 response, as the
background genetic factors are less well characterized and
more widely distributed than MHC genes. Differences may
occur in the endosomal-lysosomal proteases used to process
antigenic peptides or the type of antigen-presenting cells re-
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cruited in response to an antigenic challenge. We have recently
demonstrated that C57BL/10 (H-2b) mice are able to make a
vigorous antibody response following implantation with live
worms (1). B10.D2 mice are a congenic strain derived from
C57BL/10 but carrying the H-2d locus (14). This suggests that
the C57BL/10 background is able to process appropriately the
gp15/400 for presentation by H-2b but not H-2d class II mole-
cules. Complementation experiments, in which the ability of
BALB.K mice genetically crossed with B10.D2 mice to make
antibody demonstrated that the B10.D2 nonresponder pheno-
type is a recessive characteristic. This result excludes the pos-
sibility that B10.D2 nonresponsiveness is due to tolerance in-
duced by recognition of gp15/400 in the context of H-2d as self
or degradation of the H-2d epitope by B10 processing enzymes.
The results of this study illustrate that use of a recombinant
antigen rather than a parasite-derived antigen can have signif-
icant consequences for the nature of the immune response that
is generated. Basic immunological studies, in particular, vac-
cine-based research, are frequently founded on the presump-
tion that responses to peptides reflect the response seen with
the native molecule. This can be a misleading assumption.
Whether or not gp15/400 emerges as a vaccine target, differ-
ences in response to native antigen versus recombinant antigen
have significant consequences for vaccine strategies in general
and emphasize the importance of considering the response to
critical antigens both in the context of infection and with re-
gard to the native structure of the molecule.
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